OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) provide significant additional value to routine cardiovascular risk assessment in type 2 diabetic patients. RESEARCHDESIGNANDMETHODS—We followed up to a first cardiovascular event 688 subjects (322 men, aged 596 8 years) out of 731 consecutive asymptomatic type 2 diabetic patients with$1 additional risk factor who had been prospectively screened between 1992 and 2006 for SMI by stress myocardial scintigraphy and for silent CAD by coronary angiography. RESULTS—SMI was found in 207 (30.1%) patients and CAD in 76 of those with SMI. Of the patients, 98 had a first cardiovascular event during a 5.46 3.5 (range: 0.1–19.2) year follow-up period. Cox...
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial i...
International audienceAims: To assess the evolution of silent myocardial ischaemia prevalence and of...
Background: To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevat...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
BackgroundA common argument for identifying SMI in asymptomatic diabetic patients is to intensify tr...
Clinical Research. Presentation type: Oral Presentation. Introduction: Coronary artery disease (CAD)...
The impact of the screening for asymptomatic coronary artery disease (CAD) on the cardiovascular pro...
BACKGROUND: We aimed to determine the prevalence of silent myocardial infarction (SMI) in people wit...
AbstractObjectivesThe aim of this study was to investigate the relationships between future coronary...
PURPOSE: Myocardial ischaemia is frequently silent in patients with type 2 diabetes. Although it ha...
ObjectiveTo investigate whether elevated triglycerides and low high-density lipoprotein (HDL) choles...
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial i...
Abstract Although patients with diabetes have 2 to 4 times increased risk of cardiovascular morbidit...
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial i...
International audienceAims: To assess the evolution of silent myocardial ischaemia prevalence and of...
Background: To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevat...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
BackgroundA common argument for identifying SMI in asymptomatic diabetic patients is to intensify tr...
Clinical Research. Presentation type: Oral Presentation. Introduction: Coronary artery disease (CAD)...
The impact of the screening for asymptomatic coronary artery disease (CAD) on the cardiovascular pro...
BACKGROUND: We aimed to determine the prevalence of silent myocardial infarction (SMI) in people wit...
AbstractObjectivesThe aim of this study was to investigate the relationships between future coronary...
PURPOSE: Myocardial ischaemia is frequently silent in patients with type 2 diabetes. Although it ha...
ObjectiveTo investigate whether elevated triglycerides and low high-density lipoprotein (HDL) choles...
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial i...
Abstract Although patients with diabetes have 2 to 4 times increased risk of cardiovascular morbidit...
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial i...
International audienceAims: To assess the evolution of silent myocardial ischaemia prevalence and of...
Background: To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevat...